On Monday, Shares of Xerox Corporation (NYSE:XRX), gained 0.74% to $10.91.
Several Xerox (XRX) transportation solutions and analytics innovations will be demonstrated recently as part of the grand opening of Mcity, the University of Michigan’s one-of-a-kind test site for connected and automated vehicles. The 32-acre testing facility is paving the way for a new mobility ecosystem that will completely change the way humans and cargo travel around.
Xerox will demonstrate its work in solving transportation problems of recently and tomorrow, counting:
- CloudParc technology guides drivers to accessible parking spots using cameras and small computers mounted on traffic poles to track the availability of spaces and transmit the information to tablet devices within vehicles.
- Vehicle Passenger Detection System (VPDS) uses video analytics to identify the number of occupants in a vehicle, which allows transportation and law enforcement agencies to monitor and enforce the use of High Occupancy Vehicle/High Occupancy Toll (HOV/HOT) lanes. This data is transmitted over a Dedicated Short Range Communications (DSRC) channel to signal to the driver if they are HOV/HOT qualified via a roadside sign and an in-vehicle display.
- Merge®, a city-wide smart parking solution, enables guided parking, predictive enforcement, meter and pay-by-cell administration, and demand-based pricing – all layered with analytics to enhance parking program efficiencies and reduce traffic congestion.
Xerox Corporation provides business process and document administration solutions worldwide. The company’s Services segment offers various business process outsourcing services, such as customer care, transaction processing, human resources, communication and marketing, and consulting and analytics services, in addition to finance, accounting, and procurement services.
Shares of JD.com, Inc. (NASDAQ:JD), declined -0.74% to $35.06, during its last trading session.
JD.com, Inc., declared the launch of its U.S. Mall, a new channel on the company’s JD Worldwide cross-border platform dedicated exclusively to offering authentic imported U.S. products for sale to its customers in China.
JD.com also declared a partnership with DHL Global Forwarding to assist American brands ensure that their products reach Chinese consumers more quickly and easily. Through this partnership, DHL is the preferred logistics service provider for moving American products ordered on JD.com’s U.S. Mall to and across China.
The launch event, hosted by JD.com founder and CEO Richard Liu, comprises several hundred representatives from major U.S. brands.
JD.com, Inc., through its auxiliaries, operates as an online direct sales company in the People’s Republic of China. It primarily offers electronics and home appliances products; and general merchandise products, counting audio and video products, and books.
Finally, Boston Scientific Corporation (NYSE:BSX), ended its last trade with -0.33% loss, and closed at $17.88.
Boston Scientific Corporation, has initiated a study of the company’s first fully resorbable drug-eluting scaffold system. The Fully Absorbable Scaffold Feasibility Study (FAST) is a prospective, single arm study designed to assess the safety and performance of this next generation scaffold for the treatment of atherosclerotic coronary lesions.
The first patients in the study were enrolled by Professor Ian Meredith, primary investigator and director of MonashHeart, at Monash Medical Centre in Melbourne, Australia. The study will enroll up to 30 patients.
The resorbable polymer scaffold incorporates several key design elements from the Boston Scientific SYNERGY™ Stent System, counting a resorbable polymer and an ultrathin everolimus coating which is applied abluminally (on the exterior) to the scaffold. It also features a delivery system built with Boston Scientific expertise designed to facilitate improved acute performance.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Administration, and MedSurg.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.